Table Of Content

CUMULATIVE TABLE OF CONTENTS, VOLUME 19 Number 1 erosclerosis, Felix C. Tanner, M.D., Chantal M. Boulanger, Ph.D., CLOTTING FACTOR CONCENTRATES and Thomas F. Liischer, M.D. IN CLINICAL PRACTICE Abstracts of Current Literature, Rodger L. Bick, M.D., F.A.C.P., William A. Fricke, M.D., and Mary Ann Lamb, Ph.D. Genesio Murano, Ph.D., Meyer M. Samama, M.D., and Ernst Wenzel, M.D., Editors Therapy of Factor VIII Deficiency, Joan Cox Gill, M.D. Treatment of Factor VIII Inhibitors: Products and Strategies, B. Gail Macik, M.D. Number 3 Factor IX Concentrates for Clinical Use, Arthur R. Thompson, HEMOSTASIS IN LIVER TRANSPLANTATION M.D., Ph.D. Hanno Riess, M.D. Therapy of von Willebrand Disease, J. Paul Scott, M.D., and Robert R. Montgomery, M.D. Hemostasis in Liver Transplantation: The Surgeon’s View, Peter Therapeutic Concentrates for the Treatment of Congenital Defi- Neuhaus, M.D. ciencies of Factors VII, XI, and XIII, David Stirling, Ph.D., and Hemostasis in Advanced Liver Disease, José A. Paramo, M.D., and Christopher A. Ludiam, Ph.D., F.R.C.P., F.R.C. Path. Eduardo Rocha, M.D. Viral Safety of Clotting Factor Concentrates, William A. Fricke, Coagulation and Fibrinolysis in Orthotopic Liver Transplantation: M.D., and Mary Ann Lamb, Ph.D. Current Views and Insights, Robert J. Porte, M.D., Ph.D. Recombinant Blood Clotting Proteins for Hemophilia Therapy, Role of Leukocytes in Hemostasis During Orthotopic Liver Trans- Steven A. Limentani, M.D., David A. Roth, M.D., Barbara C. plantation, Hanno Riess, M.D., Marianne Jochum, M.D., Werner Furie, Ph.D., and Bruce Furie, M.D. Machleidt, M.D., Gabriele Himmelreich, M.D., Wolf Otto Standardization and Assay, Trevor W. Barrowcliffe, M.A., Ph.D. Bechstein, M.D., Martin Muser, Peter Neuhaus, M.D., Rolf Rois- Abstracts of Current Literature, Rodger L. Bick, M.D., F.A.C.P., sant, M.D., and Dieter Huhn, M.D. Genesio Murano, Ph.D., Meyer M. Samama, M.D., and Ernst Thrombocytopenia and Platelet Dysfunction in Orthotopic Liver Wenzel, M.D., Editors Transplantation, Gabriele Himmelreich, M.D., Karolin Hundt, Christa Isenberg, Wolf Otto Bechstein, M.D., Peter Neuhaus, M.D., and Hanno Riess, M.D. Number 2 Hemostasis in Heterotopic Liver Transplantation, Theo H.N. HEMOSTATIC REGULATION IN ATHEROSCLEROSIS Groenland, M.D., Robert J. Porte, M.D., Ph.D., C.M. Bakker, Konrad Weiss, M.D., and Helmut Sinzinger, M.D. M.D., and Jeanne Stibbe, M.D., Ph.D. Hemostasis in Children Undergoing Liver Transplantation, Mari- Heparin, Polycations, and Atherosclerosis, Stephen Hyslop, Ph.D., anne Carlier, M.D., Luc Jean Van Obbergh, M.D., Francis Veyck- and Gilberto de Nucci, M.D., Ph.D. emans, M.D., Marc de Kock, M.D., Christiane Col. de Beys, M.D., Hemorheology, Thrombogenesis, and Atherosclerosis, Edzard Edith Lavenne-Pardonge, M.D., Didier Moulin, M.D., and Jean- Emst, M.D., Ph.D., and Wolfgang Koenig, M.D., Ph.D. Bernard Otte, M.D. Fibrinogen: Its Role in the Hemostatic Regulation in Atheroscle- Retrospective Statistical Analysis of Coagulation Parameters after rosis, Bernd Eber, M.D., and Martin Schumacher, M.D. 250 Liver Transplantations, Herwig Gerlach, M.D., Klaus J. Blood Cell Activation: New Perspectives from Ultrastructural Slama, M.D., Wolf Otto Bechstein, M.D., Ruediger Lohmann, Morphometry, Giorgio Bianciardi, Ph.D., Piero Tanganelli, M.D.., M.D., Guenter Hintz, M.D., Klaus Abraham, M.D., Peter Neuhaus, and Giorgio Weber, M.D. M.D., and Konrad Falke, M.D. Hypercholesterolemia and Platelets, Elena Tremoli, Ph.D., Susanna Intraoperative Monitoring and Postoperative Reevaluation of He- Colli, Ph.D., Paola Maderna, Ph.D., Damiano Baldassarre, and mostasis in Orthotopic Liver Transplantation, Shahnaz Christina Giovanni Di Minno, M.D. Azad, Michael A.A. Kratzer, M.D., Joachim Groh, M.D., Martin Platelets in Diabetes: The Role in the Hemostatic Regulation in Welte, M.D., Matthias Haller, M.D., and Ekkehard Pratschke, Atherosclerosis, Diethelm Tschoepe, M.D., Peter Roesen, Ph.D., M.D. Barbara Schwippert, Ph.D., and Friedrich A. Gries, M.D. Laboratory Measures of Hemostasis for Monitoring Liver Graft Omega-6 and Omega-3 Essential Fatty Acids in Atherosclerosis, Function, Marco Moia, M.D., Ida Martinelli, M.D., and Pier David F. Horrobin, M.D. Mannuccio Mannucci, M.D. Lipoproteins and Prostacyclin Stability, Christian Pirich, M.D., Factor XIII Activity during Orthotopic Liver Transplantation, Martin Banyai, M.D., Yannis Efthimiou, M.D., and Helmut Sinz- Gabriele Himmelreich, M.D., Christian Miiller, Ph.D., Christa inger, M.D. Isenberg, Wolf Otto Bechstein, M.D-:, Rolf Roissant, M.D., and 13,14-Dihydro-Prostaglandin E, in Atherosclerosis, Dirk Pallapies, Hanno Riess, M.D. M.D., and Bernhard A. Peskar, M.D. Soluble Thrombomodulin Levels during Orthotopic Liver Trans- Altering Vessel Wall Fatty Acid Metabolism: A New Strategy for plantation, Matthias Riewald, M.D., Gabriele Himmelreich, M.D., Antithrombotic Treatment, Michael R. Buchanan, Ph.D., and Peter Breindl, Peter Neuhaus, M.D., and Hanno Riess, M.D. Stephanie J. Brister, M.D. Therapeutic Impact of Orthotopic Liver Transplantation on Dis- Interactions Between Nitric Oxide and Prostacyclin, Ryszard J. orders of Hemostasis, Petra Fischbach, M.D., and Inge Scharrer, Gryglewski, M.D. M.D. Endothelium-Derived Nitric Oxide, Endothelin, and Platelet Vessel Clinical Use of Synthetic Antifibrinolytic Agents during Liver Wall Interaction: Alterations in Hypercholesterolemia and Ath- Transplantation, Yoogoo Kang, M.D. 424 SEMINARS IN THROMBOSIS AND HEMOSTASIS—VOLUME 19, NO. 4, 1993 Aprotinin in Orthotopic Liver Transplantation, Wolf Otto Changes in Urokinase-Type Plasminogen Activator in Orthotopic Bechstein, M.D., Hanno Riess, M.D., Gerhard Blumhardt. M.D.., Liver Transplantation, Gabriele Himmelreich, M.D., Gerard Doo- Gabriele Himmelreich, M.D., Marianne Jochum, M.D., Herwig ijewaard, M.D., Peter Breinl, Wolf O. Bechstein, M.D., Gerhard Gerlach, M.D., Rolf Rossaint, M.D., Heinrich Keck, M.D., and Blumhardt, M.D., Cornelius Kluft, M.D., and Hanno Riess, M.D. Peter Neuhaus, M.D. Abstracts of Current Literature, Rodger L. Bick, M.D., F.A.C.P., Antithrombin III Replacement in Orthotopic Liver Transplanta- Genesio Murano, Ph.D., Meyer M. Samama, M.D., and Ernst tion, Sergio Coccheri, M.D., and Gualtiero Palareti, M.D. Wenzel, M.D., Editors Influence of Prostaglandin E, Infusion on Hemostasis in Orthotopic Scholarly Potpourri, Ernst Wenzel, M.D., Editor Liver Transplantation, Gabriele Himmelreich, M.D., Karolin Hundt, Wolf Otto Bechstein, M.D., Rolf Rossaint, M.D., Peter Neuhaus, M.D., and Hanno Riess, M.D. Coagulation Studies during Liver Transplantation in Man: Two Historical Case Reports, Smilja Popov-Ceni¢, M.D., and Hans- Number 4 Jorg Hertfelder, Ph.D. THROMBIN AND HEMOSTASIS: IV “Goal-Directed” Transfusion Management Leads to Distinct Re- John W. Fenton II, Ph.D., F.A.C.B. duction of Fluid Requirement in Liver Transplantation, Herwig Gerlach, M.D., Rolf Rossaint, M.D., Wolf Otto Bechstein, M.D., Spatial Structure of Thrombin as a Guide to Its Multiple Sites of Gerhard Blumhardt, M.D., Peter Neuhaus, M.D., and Konrad Interaction, Wolfram Bode, Dr. rer. nat., and Milton T. Stubbs, D. Falke, M.D. Phil. (Oxon.) Role of Protein S in Orthotopic Liver Transplantation, Gabriele Electrostatic Properties of Thrombin: Importance for Structural Himmelreich, M.D., Rosemarie Rosch, Peter Neuhaus, M.D., and Stabilization and Ligand Binding, Andrej Karshikov, Dr. rer. nat. Hanno Riess, M.D. and Wolfram Bode, Dr. rer. nat. The “Lytic State” during Orthotopic Liver Transplantation: Plas- A Model for the Specificity of Fibrinogen Cleavage by Thrombin, minogen Activators and Other Protease Activities, Gualtiero Milton T. Stubbs, D. Phil. (Oxon.), and Wolfram Bode, Dr. rer. nat. Palareti, M.D., Cristina Legnani, Ph.D., Alighieri Mazziotti, M.D., Crystallographic Determination of Thrombin Complexes With Marco Zanello, M.D., Claudia Sama, M.D., and Sergio Coccheri, Small Synthetic Inhibitors as a Starting Point for the Receptor- M.D. Based Design of Antithrombotics, Margit Bauer, Dr. rer. nat., Effectiveness of Aprotinin in Orthotopic Liver Transplantation, Hans Brandstetter, Dipl. Phys., Dusan Turk, Dr. rer. nat., Jorg Manuel Suarez, M.D., Bruno Sangro, M.D., Jose I. Herrero, M.D., Stiirzebecher, Dr. rer. nat., and Wolfram Bode, Dr. rer. nat. Antonio Picardi, M.D., Jose A. Paramo, M.D., Jorge Quiroga, Thrombin Interactions With Fibrinogen and Fibrin, Michael W. M.D., Fernando Pardo, M.D., Javier A-Cienfuegos, M.D., Jose Mosesson, M.D. Carrera, M.D., Francisco Hidalgo, M.D., Francisco Carrascosa, Effect of Rabbit Activated Protein C on Thrombin Generation and M.D., Eduardo Rocha, M.D., and Jestis Prieto, M.D. Fibrinolysis in a Species-Specific In Vivo Model: Effect of Effect of Aprotinin on Coagulation Parameters in Liver Trans- Modulation of Protein S Activity, Ralph E. Weinstein, M.D., and plantation, Martin Welte, M.D., Joachim Groh, M.D., Shahnaz Frederick J. Walker, Ph.D. Azad, Matthias Anthuber, M.D., Matthias Haller, M.D., and a-Thrombin Receptors and Growth Signaling, Ellen Van Ob- Michael A.A. Kratzer, M.D. berghen-Schilling, Ph.D., and Jacques Pouysségur, Ph.D. Effect of Two Different Dosages of Aprotonin on Perioperative Inherited Dysfibrinogenemias: Emerging Abnormal Structure As- Blood Loss during Liver Transplantation, Brigitte Ickx, M.D., sociations With Pathologic and Nonpathologic Dysfunctions, Olivier Pradier, M.D., Francoise Degroote, M.D., Cosette Hen- Dennis K. Galanakis, M.D. drice, M.D., Michel Toungouz, M.D., Jean Vandestadt, M.D., Factor XI Activation by Thrombin and Factor XIa, David Gailani, Michel Gelin, M.D., and Paul Capel, M.D. M.D., and George J. Broze, Jr., M.D. Influence of High-Dose Aprotinin on Hemostasis and Blood Re- Prothrombin Conversion to Thrombin by Plasminogen Activator quirement in Orthotopic Liver Transplantation, Hannelore Residing in the Subendothelial Extracellular Matrix, Miriam Grosse, M.D., Wolfgang Lobbes, M.D., Martin Frambach, M.D., Benezra, Ph.D., Israel Vlodavsky, Ph.D., and Rachel Bar-Shavit, Burckhardt Ringe, M.D., Ph.D., and Monika Barthels, M.D. Ph.D Does Aprotinin Really Reduce Blood Loss in Orthotopic Liver Coagulation Abnormalities in Patients With Precocious Coronary Transplantation? Joachim Groh, M.D., Martin Welte, M.D., Artery Thrombosis and Patients Failing Coronary Artery By- Shahnaz Christina Azad, Matthias Anthuber, M.D., Matthias Haller, pass Grafting and Percutaneous Transcoronary Angioplasty, M.D., and Michael A.A. Kratzer, M.D. Rodger L. Bick, M.D., F.A.C.P., Yahya Ismail, M.D., and William Recovery of Antithrombin III in Patients Undergoing Orthotopic F. Baker, Jr., M.D., F.A.C.P. Liver Transplantation after Administration of an Antithrombin Abstracts of Current Literature, Rodger L. Bick, M.D., F.A.C.P., Ill Concentrate, Ralf U. Scherer, M.D., Stefan Gédde, Reiner M. Genesio Murano, Ph.D., Meyer M. Samama, M.D., and Ernst Giebler, M.D., Martin J. Schmutzler, M.D., Jochen Erhard, M.D., Wenzel, M.D., Editors and Wolfgang J. Kox, M.D., Ph.D. Author Index and Cumulative Table of Contents, Volume 19